17-b-estradiol hemihydrate

Developed for: cardiovascular disorder
Investigated by: Emil Aaltonen Foundation · Finnish Medical Foundation · Päivikki and Sakari Sohlberg Foundation, Finland · University of Helsinki

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT00668603	Aug 2005 → Mar 2008	cardiovascular disorder	University of Helsinki	Completed	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	17-b-estradiol hemihydrate	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00668603 ↗
Route	Other	“transdermal estradiol gel (1 mg)” PMID 20443719 ↗ Oct 2010